Axel-Sven Malkomes

Axel-Sven brings more than 30 years of experience in finance, capital markets, M&A, and corporate leadership across the life sciences sector. Most recently, he served as Chief Financial Officer of CureVac N.V., where he played a key role in the company’s transformation and in its acquisition by BioNTech.

Previously, he served as CFO of Cardior Pharmaceuticals, where he supported major financing and strategic transactions leading to its acquisition by Novo Nordisk. He also served as CFO/CBO of Medigene AG, where he helped reshape the company strategically and financially.

Earlier in his career, Axel-Sven held senior healthcare investment banking roles at Barclays and Société Générale and private equity leadership positions at 3i Group plc. He also held senior corporate and operational leadership roles at Merck KGaA.

He holds a degree in Business Administration from Otto-Friedrich University Bamberg and completed executive programs at INSEAD, Kellogg School of Management, and HKUST.